On March 20, 2013, Zhou, Qingfu; Liu, Wenli published a patent.Name: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Compound sulfaquinoxaline sodium composition for treating coccidiosis of young rabbits. And the patent contained the following:
The title composition contains toltrazuril 0.5-1, sulfaquinoxaline sodium 4-6, trimethoprim lactate 0.8-1.2, sodium citrate 15-25, sodium CM-cellulose 1.5-2.5, sodium sulfite 0.2-0.5, EDTA-2Na 0.2-0.5 weight part, and distilled water. The preparation method of the composition comprises: taking all materials, grinding, screening via 80 mesh sieve; taking sodium sulfite and EDTA-2Na, dissolving in distilled water sequentially, stirring uniformly, adding sodium citrate, mixing for 5-10min; adding toltrazuril, sulfaquinoxaline sodium and trimethoprim lactate, mixing for 5-10min, adding sodium CM-cellulose, stirring uniformly, and filtering. The composition has simple preparation method, and obvious curative effect on coccidiosis of young rabbits. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Name: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
The Article related to sulfaquinoxaline sodium composition coccidiosis, Pharmaceuticals: Formulation and Compounding and other aspects.Name: 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia